Saybrook Capital Pfizer Inc Transaction History

Saybrook Capital

$346 Million
Q3 2024

A detailed history of Saybrook Capital transactions in Pfizer Inc stock. As of the latest transaction made, Saybrook Capital holds 14,500 shares of PFE stock, worth $364,385. This represents 0.12% of its overall portfolio holdings.

Number of Shares

14,500

Previous 15,435 6.06%

Holding current value

$364,385

Previous $432,000 3.01%

% of portfolio

0.12%

Previous 0.12%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $25,899 - $29,349	-935 Reduced 6.06%	14,500 $419,000
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $290,490 - $340,400	-11,500 Reduced 42.7%	15,435 $432,000
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $41,320 - $61,250	-1,000 Reduced 3.58%	26,935 $1.59 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $66,940 - $85,120	-2,000 Reduced 6.68%	27,935 $1.03 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $156,624 - $190,008	-5,200 Reduced 14.8%	29,935 $979,000
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $56,060 - $80,097	-2,074 Reduced 5.57%	35,135 $1.15 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $56,060 - $80,097	2,074 Added 5.9%	37,209 $1.1 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $75,000 - $82,400	-2,000 Reduced 5.39%	35,135 $1.49 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $17,773 - $20,263	-462 Reduced 1.23%	37,135 $1.62 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $4,557 - $5,020	-147 Reduced 0.39%	37,597 $1.34 Million
Q2 2017 Aug 14, 2017	BUY	N/A	37,744	37,744 $1.27 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saybrook Capital , based on Form 13F filings with the SEC.

News

Stay updated on Saybrook Capital with notifications on news.

Account

Saybrook Capital Pfizer Inc Transaction History